Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Parkinson disease”

Impact of Force Control of Hip Abductor Muscles in Healthy Adults and Individuals With Parkinson's DiseaseRecruiting
NCT07568951N/AUpdated May 8, 2026
Sponsor: Chang Gung Memorial Hospital
Aging · Parkinson's Disease (PD)
Taiwan
Psilocybin Therapy for Psychological Distress in Palliative PatientsRecruiting
NCT06782724Phase 2Updated May 8, 2026
Sponsor: University Medical Center Groningen
COPD (Chronic Obstructive Pulmonary Disease) · ALS (Amyotrophic Lateral Sclerosis) · MS (Multiple Sclerosis) · Major Depressive Disorder (MDD)
Czechia, Denmark, Netherlands, Portugal
Investigations of Dementia in Parkinson DiseaseRecruiting
NCT02763683N/AUpdated May 8, 2026
Sponsor: Washington University School of Medicine
Parkinsons
United States
Changes in Movement, Fitness, and Quality of Life in People With Parkinson's Disease After Different Exercise ProgramsRecruiting
NCT07221266NAUpdated May 8, 2026
Sponsor: University of Texas, El Paso
Parkinson Disease (PD)
United States
Aim 3 Particle Swarm Optimization PIGDRecruiting
NCT05934747NAUpdated May 8, 2026
Sponsor: University of Minnesota
Parkinson's Disease and Parkinsonism
United States
Probiotic Treatment for Depression and Associated Mood Disorders in Parkinson's DiseaseRecruiting
NCT05568498Phase 2Updated May 8, 2026
Sponsor: University of British Columbia
Parkinson Disease · Depression · PARKINSON DISEASE (Disorder)
Canada
Eye Gaze Strategies During Facial Emotion Recognition in Neurodegenerative Diseases: Links With Neuropsychiatric Disorders (EYE-ToM Study)Completed
NCT04748263N/AUpdated May 8, 2026
Sponsor: Centre Hospitalier Princesse Grace
Alzheimer's Dementia · Parkinson Disease(PD) · Fronto-Temporal Dementia
Feasibility Of Objective Measures and Outpatient Washout in Disease Modifying Trials for Parkinson's DiseaseCompleted
NCT06192823N/AUpdated May 8, 2026
Sponsor: Vanderbilt University Medical Center
Parkinson Disease
United States
Closed-loop TMS for TremorRecruiting
NCT07574164NAUpdated May 7, 2026
Sponsor: University of Oxford
Essential Tremor · Parkinson's Disease (PD)
United Kingdom
O-ARM Stereotactic Imaging in Deep Brain Stimulation for Parkinson's DiseaseCompleted
NCT05910008NAUpdated May 7, 2026
Sponsor: University Hospital, Toulouse
Parkinson Disease
France
Pathophysiology of Neuronal Oscillations Within Subthalamo-cortical Loops in Parkinson's DiseaseCompleted
NCT01284686NAUpdated May 7, 2026
Sponsor: Assistance Publique Hopitaux De Marseille
Parkinson's Disease · Pathophysiology of Neuronal Oscillations Within Subthalamo-cortical Loops
France
Effects of RAS on Gait in PD Patients With DBSRecruiting
NCT05763732NAUpdated May 6, 2026
Sponsor: Johns Hopkins University
Parkinson Disease
United States
Functional Neuroimaging in Parkinson's DiseaseCompleted
NCT04904068N/AUpdated May 6, 2026
Sponsor: University of Delaware
Parkinson Disease · Healthy Aging
United States
Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's DiseaseCompleted
NCT04232969Phase 3Updated May 6, 2026
Sponsor: University College, London
Parkinson's Disease
United Kingdom
Combined Deep Brain Stimulation in Parkinson's DiseaseCompleted
NCT05415774NAUpdated May 6, 2026
Sponsor: University Hospital, Toulouse
Parkinson Disease
France
Therapeutic Education in Parkinson's Disease: What Impact on Drug Representations of Patients? (ETPARK-REMED)Completed
NCT04228523NAUpdated May 6, 2026
Sponsor: University Hospital, Toulouse
Parkinson Disease
France
A Prospective, Randomized, Controlled Trial to Test Safety and Effectiveness of Unilateral Exablate MR-guided Focused Ultrasound Subthalamotomy in Patients With Early-Stage Parkinson's DiseaseActive Not Recruiting
NCT06584383NAUpdated May 6, 2026
Sponsor: InSightec
Parkinson Disease
Chile, Germany, Spain
Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)Active Not Recruiting
NCT05173987Phase 3Updated May 5, 2026
Sponsor: Merck Sharp & Dohme LLC
Endometrial Neoplasms
United States, Australia, Belgium, Brazil, Canada +22 more
Reliability and Validity of Sensor-derived Measurements in Individuals With Parkinson's Disease: Preliminary Results From the INERTIAL StudyCompleted
NCT07567079N/AUpdated May 5, 2026
Sponsor: Francesca Cecchi
Parkinson Disease
Italy
Attention and Eye Movement in Parkinson's DiseaseRecruiting
NCT06899022NAUpdated May 5, 2026
Sponsor: University of Nebraska
Essential Tremor · Parkinson's Disease (PD) · Dystonias
United States
Simplified, Scalable, 24-hour Adaptive DBS in Parkinson's DiseaseRecruiting
NCT07398157NAUpdated May 5, 2026
Sponsor: University of California, San Francisco
PD - Parkinson's Disease
United States
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)Completed
NCT03797326Phase 2Updated May 4, 2026
Sponsor: Merck Sharp & Dohme LLC
Advanced Solid Tumors · Triple Negative Breast Cancer · Ovarian Cancer · Gastric Cancer
United States, Argentina, Australia, Canada, Chile +12 more
Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.Recruiting
NCT07064005Phase 1Updated May 4, 2026
Sponsor: Pravat Mandal
Parkinsons Disease (PD)
United States
Cerebellar Transcranial Alternating Current Stimulation (tACS) to Modulate Parkinson's Disease TremorRecruiting
NCT06993571NAUpdated May 4, 2026
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Parkinson's Disease (PD) · Tremor
Germany
Effects of PR Oxycodone and of Levodopa, vs Placebo, on Central Neuropathic Pain in Parkinson's DiseaseCompleted
NCT02601586Phase 2, Phase 3Updated May 4, 2026
Sponsor: University Hospital, Toulouse
Parkinson Disease
France

Previous page Next page